Krebs Biochemicals and Industries Limited

Web: krebsbiochem.com NSE: KREBSBIO BSE: 524518 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

56 1(2%)

Volume

4k as on 23, Jun

Open

High

Low

VWAP

52 Week High

52 Week Low

Viand Research Rating

Quality Score

37/100

Growth Score

11/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

120

No. of Shares

2.16

P/E

-11.21

P/B

-2.05

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

18.25

ROCE

Profit Growth

Listing Date

03-Jan-96

Promoter Holding

72.74%

FII Holding

0.5%

DII Holding

Price Chart

Price Performance

1 Week2%

1 Month11%

3 Months42%

6 Months14%

1 Year14%

YTD14%

Moving Average

5 Day SMA65

10 Day SMA65

20 Day SMA65

30 Day SMA63

50 Day SMA58

61 Day SMA58

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	70	65	69	70
Resistance 2	69	65	68	69
Resistance 1	67	65	67	67
Pivot Point	66	65	66	66
Support 1	64	64	64	64
Support 2	62	64	64	63
Support 3	60	64	62	61

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 72.74%	(0.01) 72.74%	(0.01) 72.74%	(0.01) 72.74%	(0.01) 72.74%	(0.01) 72.74%	(0.01) 72.74%	(0.01) 72.74%	(0.01) 72.74%	(0.01) 72.74%	(0.01) 72.74%	(0.01) 72.74%	(0.01) 72.74%	(0.01) 72.74%	(0.01) 72.72%	(0.01) 72.74%	(0.01) 72.74%	(0.01) 72.74%	(0.01) 72.74%	(0.01) 72.74%
FIIs	(0.01) 0.50%	(0.01) 0.50%	(0.01) 0.50%	(0.01) 0.50%	(0.01) 0.50%	(0.01) 0.50%	(0.01) 0.50%	(0.01) 0.50%	(0.01) 0.50%	(0.01) 0.50%	(0.01) 0.50%	(0.01) 0.50%	(0.01) 0.50%	(0.21) 0.50%	(0.31) 0.33%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%
Public	26.76%	26.77%	26.76%	26.76%	26.76%	26.75%	26.76%	26.76%	26.75%	26.75%	26.77%	26.76%	26.77%	26.76%	26.95%	27.26%	27.25%	27.25%	27.25%	27.25%
No. of Shareholders	8,521	8,553	8,710	8,912	9,118	8,798	9,091	9,425	8,848	8,909	8,990	9,030	9,393	9,315	9,294	9,650	9,533	9,531	8,166	8,571

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	6.98	6.81	7.27	4.17	5.48	6.1	11.47	12.86	12.89	11.97	12.98	14.89	10.58	11.46	9.09	20.94	10.64	19.16	21.81	11.98
Sales Growth % (YoY)	27.4%	11.6%	-36.6%	-67.6%	-57.5%	-49%	-11.6%	-13.6%	21.8%	4.4%	42.8%	-28.9%	-0.6%	-40.2%	-58.3%	75%	57%	20.8%	127.7%	-28.2%
Sales Growth % (QoQ)	2.5%	-6.3%	74.3%	-23.9%	-10.2%	-46.8%	-10.8%	-0.2%	7.7%	-7.8%	-12.8%	40.7%	-7.7%	26.1%	-56.6%	96.8%	-44.5%	-12.2%	82.1%	-
Expenses	6.16	7.67	6.97	6.97	7.57	11.51	16.18	15.58	15.08	15.09	15.07	15.79	13.2	16.08	12.07	22.84	16.91	28.94	31.71	19.76
Operating Profit	0.82	-0.86	0.3	-2.8	-2.09	-5.41	-4.71	-2.72	-2.19	-3.12	-2.09	-0.9	-2.62	-4.62	-2.98	-1.9	-6.27	-9.78	-9.9	-7.78
OPM %	11.75	-12.63	4.13	-67.15	-38.14	-88.69	-41.06	-21.15	-16.99	-26.07	-16.1	-6.04	-24.76	-40.31	-32.78	-9.07	-58.93	-51.04	-45.39	-64.94
Other Income	0.16	2	0	0.01	0.01	0.34	0.25	0.09	0.03	0.21	0.03	0.17	0.04	0.19	0.02	0.27	0.13	0.79	0.2	0.13
Interest	1.88	1.91	1.79	1.73	1.65	1.61	1.56	1.42	1.32	1.27	1.19	1.13	1.1	1.03	0.9	0.74	0.3	0.28	1.82	1.78
Depreciation	1.59	1.57	1.63	1.62	1.6	1.57	1.72	1.71	1.69	1.67	1.73	1.71	1.65	1.48	1.69	1.69	1.69	2.05	1.42	1.42
Profit before tax	-2.49	-2.34	-3.12	-6.14	-5.33	-8.25	-7.74	-5.76	-5.17	-5.85	-4.98	-3.57	-5.33	-6.94	-5.55	-4.06	-8.13	-11.32	-12.94	-10.85
Tax %	0	0	0	0	0	0.24	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Profit	-2.48	-2.34	-3.13	-6.14	-5.32	-8.27	-7.74	-5.76	-5.17	-5.85	-4.98	-3.57	-5.33	-6.94	-5.55	-4.06	-8.14	-11.31	-12.94	-10.85
Net Profit Growth % (QoQ)	-6%	25.2%	49%	-15.4%	35.7%	-6.8%	-34.4%	-11.4%	11.6%	-17.5%	-39.5%	33%	23.2%	-25%	-36.7%	50.1%	28%	12.6%	-19.3%	-
Net Profit Growth % (YoY)	53.4%	71.7%	59.6%	-6.6%	-2.9%	-41.4%	-55.4%	-61.3%	3%	15.7%	10.3%	12.1%	34.5%	38.6%	57.1%	62.6%	-	-	-	-
TTM Net Profit	-14.09	-16.93	-22.86	-27.47	-27.09	-26.94	-24.52	-21.76	-19.57	-19.73	-20.82	-21.39	-21.88	-24.69	-29.06	-36.45	-43.24	-35.1	-23.79	0
EPS in Rs	-1.15	-1.09	-1.45	-2.85	-2.47	-3.84	-3.59	-2.67	-2.4	-2.71	-2.31	-1.66	-2.47	-3.22	-2.57	-1.88	-3.78	-5.25	-6	-5.03

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Jan 1900
Sales	24	43	50	52	60	54	33	48	34	3	1	0
Sales Growth %	-45.2%	-14.1%	-3.3%	-12.7%	11.2%	60.7%	-30%	41.4%	945.8%	183.3%	-	-
Expenses	29	58	59	68	94	71	52	58	41	11	14	5
Operating Profit	-5	-15	-9	-16	-34	-18	-19	-10	-8	-8	-12	-5
OPM %	-23	-35	-17	-30	-57	-33	-56	-20	-22	-248	-1088	0
Other Income	2	1	0	1	1	1	0	0	-1	0	1	3
Interest	7	6	5	3	5	6	6	6	5	3	1	4
Depreciation	6	7	7	7	6	5	5	4	4	4	4	2
Profit before tax	-17	-27	-20	-25	-45	-28	-29	-20	-18	-16	-16	-8
Tax %	0	0	0	0	0	0	0	0	0	0	0	0
Net Profit	-17	-27	-20	-25	-45	-28	-29	-20	-18	-16	-16	-8
Net Profit Growth %	37%	-35%	20%	44.4%	-60.7%	3.4%	-45%	-11.1%	-12.5%	-	-100%	-
EPS in Rs	-7.85	-12.5	-9.15	-11.45	-20.65	-14.45	-16.04	-12.03	-10.73	-9.67	-10.33	-6.82
Dividend Payout %	0	0	0	0	0	0	0	0	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Sep 2014	Jun 2013
Cash from Operating Activity	-2	-8	2	-25	-17	-15	-36	4	-6	-11	-15	-45	49	-2
Cash from Investing Activity	-4	-5	-8	-13	-23	-23	-10	-4	-3	-5	-4	-3	0	6
Cash from Financing Activity	6	13	6	37	40	38	29	17	9	16	13	54	-49	-4
Net Cash Flow	0	0	0	0	-1	1	-17	17	0	0	-6	6	0	0

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Sep 2014	Jun 2013
Equity Capital	22	22	22	22	22	22	22	20	18	17	14	14	13	10	10	10
Reserves	-184	-179	-168	-152	-141	-121	-97	-62	-43	-31	-32	-12	0	9	-6	-2
Borrowings	225	219	212	205	194	183	143	111	66	53	56	48	31	61	93	93
Other Liabilities	101	106	103	111	104	91	122	91	93	103	87	73	73	29	41	37
Total Liabilities	163	168	169	185	178	175	190	159	134	142	126	122	116	108	138	138
Fixed Assets	142	146	146	149	150	147	139	118	105	101	101	102	93	58	58	51
CWIP	2	1	3	1	2	4	8	12	4	3	4	4	11	0	0	7
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	20	20	20	36	26	24	43	29	24	38	21	16	13	50	80	80
Total Assets	163	168	169	185	178	175	190	159	134	142	126	122	116	108	138	138

Delivery

Delivery Data: KREBSBIO

#	Date	51 28% 65	Q/T 193	Del 65
1	4-Sep	56	19	85
2	3-Sep	54	170	88
3	2-Sep	55	117	72
4	1-Sep	54	100	91
5	31-Aug	56	23	87
6	28-Aug	59	74	87
7	27-Aug	56	32	91
8	26-Aug	53	25	91
9	25-Aug	54	17	78
10	24-Aug	53	19	68
11	21-Aug	54	31	66
12	20-Aug	55	35	86
13	19-Aug	54	88	88
14	18-Aug	56	193	97
15	17-Aug	55	87	70
16	14-Aug	55	47	77
17	13-Aug	56	49	77
18	12-Aug	55	18	65
19	11-Aug	56	33	82
20	10-Aug	57	109	92
21	7-Aug	55	69	77
22	6-Aug	55	40	93
23	5-Aug	54	58	97
24	4-Aug	54	41	75
25	3-Aug	56	122	74
26	31-Jul	54	124	36
27	30-Jul	54	37	81
28	29-Jul	54	370	100
29	28-Jul	53	24	84
30	27-Jul	56	58	78
31	24-Jul	52	39	83
32	23-Jul	53	70	87
33	22-Jul	53	50	82
34	21-Jul	55	42	64
35	20-Jul	54	25	62
36	17-Jul	54	32	74
37	16-Jul	53	55	89
38	15-Jul	55	56	76
39	14-Jul	55	15	79
40	13-Jul	55	52	71
41	10-Jul	56	49	81
42	9-Jul	57	77	79
43	8-Jul	54	147	48
44	7-Jul	58	20	64
45	6-Jul	58	37	79
46	3-Jul	59	58	77
47	2-Jul	59	55	92
48	1-Jul	60	37	72
49	30-Jun	60	28	31
50	29-Jun	60	86	66

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	120c	30L	0.25
03-Sep	120c	2c	1.81
01-Sep	118c	5c	4.03
31-Aug	123c	7c	5.74
25-Aug	116c	54L	0.46
24-Aug	117c	2c	1.31
21-Aug	116c	2c	1.56
19-Aug	117c	2c	1.98
18-Aug	120c	1c	0.91
17-Aug	119c	1c	0.90
14-Aug	118c	3c	2.66
13-Aug	121c	3c	2.30
12-Aug	118c	3c	2.25
11-Aug	121c	0	0
10-Aug	121c	4c	3.32
06-Aug	117c	22L	0.18
04-Aug	117c	2c	1.42
03-Aug	115c	13L	0.11
31-Jul	116c	2c	1.33
30-Jul	117c	69L	0.59
29-Jul	116c	1c	1.22
28-Jul	115c	5c	3.87
27-Jul	120c	0	0

Stock Checklist

Price is above from 52 week high low average: 32%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView